Medicover AB (publ) Class B shares (0RPS)
Summary
Medicover AB (publ) Class B shares (0RPS) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Medicover AB (publ) Class B shares ever had a stock split?
Medicover AB (publ) Class B shares Profile
| Health Care Providers & Services Industry | Healthcare Sector | John Paul Stubbington CEO | LSE Exchange | W56135101 CUSIP |
| SE Country | 47,000 Employees | 30 Apr 2026 Last Dividend | - Last Split | - IPO Date |
Overview
Medicover AB (publ) is a healthcare and diagnostic service provider operating out of Stockholm, Sweden, with an extensive international presence, notably in Poland and Sweden. Since its establishment in 1995, the company has grown to offer a broad spectrum of healthcare services tailored to meet the needs of corporate entities, individuals, and public sector entities. Medicover AB is renowned for integrating medical and wellness services, thereby promoting a holistic approach to health care that extends beyond traditional medical treatments.
Products and Services
- Healthcare Services
Medicover AB's healthcare services are comprehensive, covering outpatient and inpatient care that ensures patients receive the appropriate level of care for their conditions. They also offer specialized dental services catering to various oral health needs. Beyond medical care, the company provides non-medical related services, including sports memberships, benefit cards, and optics services, as well as wellness services aimed at promoting general health and well-being. Hospital care services focus on providing full-scale hospital treatment, and preventive care services are designed to prevent diseases or detect them at an early stage, minimizing the potential health impact.
- Diagnostic Services
Medicover’s diagnostic services offer a wide array of tests essential for accurate diagnoses and effective treatment. These include allergy and autoimmune diagnostics, bacteriology, parasitology, and a comprehensive range of chemistry tests such as biochemistry, immunochemistry, clinical chemistry, and blood group diagnostics/transfusion medicine. Furthermore, they offer diagnostics in tumour markers, cytology, haematology, histopathology, human genetics, hygiene, immunology, and immunochemistry. Their services extend to encompass infectious diseases, microbiology, molecular biology, and pharmacology/toxicology tests, providing a well-rounded diagnostic capability to address a multitude of healthcare needs.
